Skip to main content
Caplight Logo









Hudson River Biotechnology

Hudson River Biotechnology

Private
WageningenHealthcare & Life Scienceshttps://www.hudsonriver.bio/

Last Round

VC Round

Apr 9, 2024

Total Funding Raised

$5.99M

Company Overview

Hudson River Biotechnology is an agricultural biotechnology company that develops new crop varieties using its proprietary DNA-free CRISPR platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

CRISPRgene editingDNA-free CRISPRagricultural biotechnologyagritechagbiotechcrop improvementplant gene editingtrait developmentprecision breedingprotoplast technologyseed companiesgenetic target identificationclimate resilient cropsornamental plantsnanotechnology deliverybioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hudson River Biotechnology Comparables

Compare Hudson River Biotechnology with similar companies based on industry and business-model similarity.

Hudson River Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phytoform Labs
87%
Qi Biodesign
84%
Pairwise
82%

Hudson River Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 9, 2024
VC RoundApr 9, 2024
Series AAug 5, 2021
SeedMar 21, 2018
GrantMar 18, 2015

Key People

Founding team and executive leadership

Ferdinand Los

Chief Executive Officer

Executive Team

Hudson River Biotechnology Investors

Notable investors and investment history

Hudson River Biotechnology investors
InvestorRounds
European Union's Horizon Research and Innovation programGrant
Bridford GroupVC Round, Series A
Oost NLVC Round
StartLifeSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2024

    Oost NL and Bridford Group led the round.

  • Apr 9, 2024

    Oost NL and Bridford Group led the round.

Hudson River Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hudson River Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hudson River Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersWageningen
Employee Range22
Year Founded2015
Last FundingApr 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?